Sarcoidosis during COVID-19 new pandemic infection
A literature review of the combination of sarcoidosis and the novel COVID-19 infection is presented. In mild forms of sarcoidosis, without a decrease in lung function and without requiring immunosuppressive therapy, no additional risks have been identified in the context of a new COVID-19 pandemic. However, at the stage of diagnosis, one should be careful about changes in CT scans in patients with COVID-19, due to their similarity with other conditions manifested by the picture of ‘frosted glass’, as is the case with sarcoidosis. Immunosuppressive therapy for sarcoidosis should be reduced to the minimum possible, leaving only that which ensures the stability of the condition. The self-isolation regimen and the willingness to seek early medical care should first of all be observed by patients with sarcoidosis with large lung lesions.